Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8821867 4-1BB binding molecules

Patent 8821867 was granted and assigned to Pfizer Limited on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Libbey Anne Yates0

Bianca Ahrens0

Kathrin Ladetzki-Baehs0

Leslie Lynne Sharp0

Michael Tesar0

Moritz Zulley0

Richard Michael Jerome0

Sangita M. Baxi0

...

Date of Patent

September 2, 2014

Patent Application Number

13676288

Date Filed

November 14, 2012

Patent Citations Received

US Patent 11981921 TIL expansion processes using specific cytokine combinations and/or AKTi treatment

0

US Patent 11999800 Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer

0

US Patent 11752207 Agonist antibodies that bind human CD137 and uses thereof

US Patent 12006347 Superagonists and antagonists of interleukin-2

0

US Patent 12104172 Processes for generating TIL products enriched for tumor antigen-specific t-cells

0

US Patent 12024718 Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

0

US Patent 11713446 Processes for generating TIL products enriched for tumor antigen-specific T-cells

0

US Patent 11851497 CD137 antibodies and tumor antigen-targeting antibodies and uses thereof

0

...

Patent Primary Examiner

Bridget E Bunner

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8821867 4-1BB binding molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool